Latest News - Veeva Systems
Top Corporates Hub
Veeva Systems
Morgan Stanley Upgrades Veeva Systems to Equal-Weight, Lowers Price Target to $205
17.02.2026 07:31
Morgan Stanley analyst Craig Hettenbach upgrades Veeva Systems (NYSE:VEEV) from Underweight to Equal-Weight and lowers the price target from $222 to $205.
Veeva Systems Inc. (VEEV) Presents at Raymond James TMT & Consumer Conference Transcript
08.12.2025 13:47
Veeva Systems Inc. (VEEV) Raymond James TMT & Consumer Conference December 8, 2025 11:20 AM ESTCompany ParticipantsPaul Shawah - Executive Vice...
BMO Capital Initiates Coverage of Veeva Systems (VEEV) with Market Perform Recommendation
13.11.2025 12:03
Is Now The Time To Look At Buying Veeva Systems Inc. (NYSE:VEEV)?
31.10.2025 14:00
Veeva Systems Inc. ( NYSE:VEEV ) saw significant share price movement during recent months on the NYSE, rising to highs...
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?
29.10.2025 17:39
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
29.10.2025 13:00
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Veeva Systems: A Great Company At The Wrong Price
24.10.2025 04:47
Veeva Systems (VEEV) shows strong fundamentals but appears overvalued. See why my analysis suggests holding off on buying at current prices.
How Veeva Systems’ (VEEV) Partnership with OpenEvidence Could Reshape Its AI-Driven Growth Narrative
20.10.2025 05:04
On October 19, 2025, OpenEvidence announced a long-term partnership with Veeva Systems to develop and market Open Vista, an AI-powered platform aimed at expanding patient access to clinical trials, accelerating drug discovery, and improving adoption of approved medicines. An interesting aspect is that OpenEvidence’s clinical decision support AI is already actively used by more than 40% of U.S. physicians, providing a strong foundation for the new platform’s healthcare reach. We'll explore...